Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Buy
59
ARKG Quote, Financials, Valuation and Earnings
Last price:
$30.13
Seasonality move
:
-2.44%
Day range:
$29.74 - $31.02
52-week range:
$17.51 - $34.07
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
2.6M
Avg. volume:
3.2M
1-year change:
29.31%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, ARK Genomic Revolution ETF has -- downside to fair value with a price target of -- per share.
ARKG vs. S&P 500
-
Over the past 5 trading days, ARK Genomic Revolution ETF has overperformed the S&P 500 by 0.54% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
ARK Genomic Revolution ETF does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ARK Genomic Revolution ETF has grown year-over-year revenues for 0 quarters straight. In the most recent quarter ARK Genomic Revolution ETF reported revenues of --.
Earnings Growth
-
ARK Genomic Revolution ETF has grown year-over-year earnings for 0 quarters straight. In the most recent quarter ARK Genomic Revolution ETF reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-24 | 2024-12-24 | 2024-12-24 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-12-24 | 2022-12-24 | 2023-12-24 | 2024-12-24 | ||
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-24 | 2024-12-24 | 2024-12-24 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
ARKG
Sector
Market Cap
--
--
Price % of 52-Week High
88.45%
--
Dividend Yield
0%
--
Shareholder Yield
--
--
1-Year Price Total Return
29.31%
--
Beta (5-Year)
1.794
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$29.85
200-day SMA
Buy
Level
$25.41
Bollinger Bands (100)
Buy
Level
25.32 - 30.82
Chaikin Money Flow
Sell
Level
-57.7M
20-day SMA
Buy
Level
$30.44
Relative Strength Index (RSI14)
Buy
Level
54.72
ADX Line
Buy
Level
12.13
Williams %R
Neutral
Level
-43.8312
50-day SMA
Buy
Level
$30.01
MACD (12, 26)
Buy
Level
0.08
25-day Aroon Oscillator
Buy
Level
44
On Balance Volume
Sell
Level
-155.1M
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, ARKG has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ARKG average analyst price target in the past 3 months is --.
-
Where Will ARK Genomic Revolution ETF Stock Be In 1 Year?
According to analysts, the consensus estimate is that ARK Genomic Revolution ETF share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About ARK Genomic Revolution ETF?
Analysts are divided on their view about ARK Genomic Revolution ETF share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ARK Genomic Revolution ETF is a Sell and believe this share price will rise from its current level to --.
-
What Is ARK Genomic Revolution ETF's Price Target?
The price target for ARK Genomic Revolution ETF over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ARKG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ARK Genomic Revolution ETF is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ARKG?
You can purchase shares of ARK Genomic Revolution ETF via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ARK Genomic Revolution ETF shares.
-
What Is The ARK Genomic Revolution ETF Share Price Today?
ARK Genomic Revolution ETF was last trading at $30.13 per share. This represents the most recent stock quote for ARK Genomic Revolution ETF. Yesterday, ARK Genomic Revolution ETF closed at $30.62 per share.
-
How To Buy ARK Genomic Revolution ETF Stock Online?
In order to purchase ARK Genomic Revolution ETF stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get ARKG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ARKG
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
--
--
Price / LTM sales
--
--
Growth Metrics
ARKG
Sector
Revenue growth
--
--
Earnings growth
--
--
Revenue (5-year growth)
--
--
Earnings forecast
--
--
Profitability
ARKG
Sector
Profitability FY 2025
--
--
Return on invested capital
--
--
Return on assets
--
--
Return on equity
--
--
Earnings Date
Last Earnings Date
Dec
24
Next Earnings Date
Dec
24
Estimated Next Earnings Date
Mar
25
Balance Sheet
ARKG
Sector
Total cash
--
--
Short term investments
--
--
Total assets
--
--
Long term debt
--
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 23
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
